ACTIVE

Oxurion

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-3,2 M €

-1524.8% YoY

Revenue

644,5 €

-78.2% YoY

Equity

-12,2 M €

-15.6% YoY

Workforce

7,3 ETP

-13.1% YoY

What does Oxurion do?

Oxurion is a Public limited company incorporated in 2006. Its main activity is: Activities of head offices. Its registered office is in Leuven. It employs on average 7,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0881.620.924

Incorporation

30/05/2006

Legal form

Public limited company

Registered office

Gaston Geenslaan 1
3001 Leuven · FlandreSee on map

Contributed capital

87 156 461,00 €

Latest accounts

31/12/2025

Average workforce

7,3 ETP

Activities (NACE)

70100Activities of head offices· main 64210Activities of holding companies

Joint committees (2)

Contacts

3 public details availableLog in to view

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2008
Income statement
Revenue	644,5 €	-78.2%	3 k €	-98.9%	262,6 k €	-55.9%	595,4 k €	-43.5%	1,1 M €	-46.1%	2 M €	-36.1%	3,1 M €	-30.9%	4,4 M €	-41.6%	7,6 M €	+103%	3,7 M €	-17.0%	4,5 M €	-42.2%	7,8 M €	-92.2%	99,9 M €	+33.0%	75,1 M €	+2767%	2,6 M €	-59.9%	6,5 M €	-78.3%	30,1 M €
EBITDA	-3,4 M €	-1055%	360,6 k €	+132%	-1,1 M €	+76.4%	-4,8 M €	-242%	-1,4 M €	+84.6%	-9,1 M €	+70.1%	-30,6 M €	-120%	-13,9 M €	-130%	47,1 M €	+206%	-44,3 M €	-93.8%	-22,9 M €	+53.1%	-48,8 M €	-228%	38,1 M €	+15.9%	32,8 M €	+253%	-21,5 M €	-49.1%	-14,4 M €	-212%	12,9 M €
Operating result	-3,4 M €	-1110%	340,9 k €	+103%	-12,2 M €	+46.3%	-22,8 M €	+10.5%	-25,4 M €	+7.9%	-27,6 M €	+46.0%	-51,1 M €	-32.8%	-38,5 M €	-256%	24,7 M €	+136%	-68,1 M €	-111%	-32,3 M €	+42.0%	-55,7 M €	-448%	16 M €	-17.9%	19,5 M €	+156%	-34,6 M €	-25.5%	-27,6 M €	-319%	12,6 M €
Net result	-3,2 M €	-1525%	-199,2 k €	+98.5%	-13,4 M €	+45.4%	-24,5 M €	+33.3%	-36,7 M €	-36.4%	-26,9 M €	+46.4%	-50,2 M €	-35.9%	-36,9 M €	-255%	23,8 M €	+135%	-67,3 M €	-129%	-29,4 M €	+42.6%	-51,2 M €	-465%	14 M €	-32.5%	20,8 M €	+166%	-31,5 M €	-17.4%	-26,8 M €	-290%	14,1 M €
Balance sheet
Equity	-12,2 M €	-15.6%	-10,5 M €	+13.9%	-12,2 M €	-90.4%	-6,4 M €	-362%	-1,4 M €	-104%	34 M €	-44.2%	60,9 M €	-45.2%	111,1 M €	-19.5%	137,9 M €	+20.9%	114,1 M €	-37.1%	181,4 M €	-14.0%	210,8 M €	-19.6%	262 M €	+6.9%	245,1 M €	+69.8%	144,3 M €	-17.7%	175,3 M €	+41.7%	123,7 M €
Total assets	2,8 M €	-18.7%	3,5 M €	-40.1%	5,8 M €	-31.2%	8,4 M €	-49.6%	16,8 M €	-59.2%	41,1 M €	-40.8%	69,3 M €	-42.2%	120 M €	-22.1%	154,1 M €	+24.5%	123,7 M €	-34.2%	187,9 M €	-13.9%	218,1 M €	-19.0%	269,2 M €	-1.5%	273,4 M €	+78.4%	153,2 M €	-14.8%	179,8 M €	+38.3%	130 M €
Cash	244,5 k €	-33.4%	367,3 k €	-77.0%	1,6 M €	-51.8%	3,3 M €	-64.9%	9,4 M €	-60.2%	23,7 M €	-43.9%	42,2 M €	-34.5%	64,5 M €	+3.3%	62,4 M €	+14.7%	54,4 M €	-41.1%	92,4 M €	-21.7%	118 M €	-16.3%	141 M €	+14.3%	123,3 M €	+284%	32,1 M €	-25.9%	43,3 M €	+156%	16,9 M €
Debts	14,3 M €	+5.9%	13,5 M €	-23.5%	17,6 M €	+23.5%	14,3 M €	-19.4%	17,7 M €	+183%	6,3 M €	-5.8%	6,6 M €	-4.7%	7 M €	-51.2%	14,3 M €	+161%	5,5 M €	+51.5%	3,6 M €	-32.2%	5,3 M €	-24.0%	7 M €	-74.7%	27,7 M €	+247%	8 M €	+82.3%	4,4 M €	-23.0%	5,7 M €
Other
Workforce	7,3 ETP	-13.1%	8,4 ETP	-41.7%	14,4 ETP	-46.1%	26,7 ETP	-38.1%	43,1 ETP	-28.4%	60,2 ETP	-12.8%	69,0 ETP	+10.9%	62,2 ETP	-2.4%	63,7 ETP	-7.1%	68,6 ETP	-7.3%	74,0 ETP	-18.7%	91,0 ETP	-5.9%	96,7 ETP	+14.3%	84,6 ETP	+21.0%	69,9 ETP	+41.2%	49,5 ETP	+56.6%	31,6 ETP

Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 74 ended

Active mandates

Nelly Souleymane

Director · since 14 février 2025 · until 04 mai 2027

Active

Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 04 mai 2027

Active

James Hartmann

Director · since 28 décembre 2023 · until 04 mai 2027

Active

MARS SARL

Director · since 28 décembre 2023 · until 04 mai 2027

Represented by Pascal Ghoson

Active

Anat Loewenstein

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Nathalie Laarakker

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Ended mandates

Nelly Souleymane

Director · since 14 février 2025 · until 06 mai 2025

Ended

Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 07 mai 2024

Ended

James Hartmann

Director · since 28 décembre 2023 · until 07 mai 2024

Ended

MARS SARL

Director · since 28 décembre 2023 · until 07 mai 2024

Represented by Pascal Ghoson

Ended

At this address

Other companies at this address

Company	CBE no.
ALIGOS BELGIUM● Active	0702.969.886
Bio-Incubator Leuven● Active	0876.605.232
Community Building Arenberg● Active	1014.096.594
Creative Biolabs Belgium● Active	1028.942.544
DName-iT● Active	0506.754.823
Fisherman● Active	0804.287.079
Fishway● Active	0787.869.632
Formac Pharmaceuticals● Active	0892.914.395
IDA INTERNATIONAL● Active	1002.119.470
Lever Bio Belgium● Active	1039.455.958
Maatschap reMYND● Active	1019.655.090
miDiagnostics● Active	0641.984.602
PALEO● Active	0756.986.614
PARKEERGEBOUW● Active	1009.039.728
Pledge Therapeutics● Active	0726.743.301
Qmineral● Active	0837.633.897
Raya Therapeutic● Active	1003.128.171
ReGenesys● Active	0877.070.337
ReGenesys EU● Active	0544.577.301
reMYND● Active	0476.910.101

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	27/06/2025	18/06/2024	01/06/2023	08/06/2022	18/06/2021
General meeting	01/06/2026	13/05/2025	16/05/2024	02/05/2023	03/05/2022	04/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

31 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	01/06/2026	30/06/2026	Dutch	PDF
Full model	31/12/2024	13/05/2025	27/06/2025	Dutch	PDF
Consolidated accounts	31/12/2024	13/05/2025	27/06/2025	Dutch	PDF
Full model	31/12/2023	16/05/2024	18/06/2024	Dutch	PDF
Consolidated accounts	31/12/2023	16/05/2024	18/06/2024	Dutch	PDF
Full model	31/12/2022	02/05/2023	01/06/2023	Dutch	PDF
Consolidated accounts	31/12/2022	02/05/2023	01/09/2023	Dutch	PDF
Full model	31/12/2021	03/05/2022	08/06/2022	Dutch	PDF
Full model	31/12/2020	04/05/2021	18/06/2021	Dutch	PDF
Consolidated accounts	31/12/2020	04/05/2021	18/06/2021	Dutch	PDF
Full model	31/12/2019	05/05/2020	27/05/2020	Dutch	PDF
Consolidated accounts	31/12/2019	05/05/2020	27/05/2020	Dutch	PDF
Full model	31/12/2018	07/05/2019	06/06/2019	Dutch	PDF
Consolidated accounts	31/12/2018	01/01/9999	07/06/2019	Dutch	PDF
Full model	31/12/2017	02/05/2018	28/05/2018	Dutch	PDF
Consolidated accounts	31/12/2017	02/05/2018	05/07/2018	Dutch	PDF
Full model	31/12/2016	02/05/2017	01/06/2017	Dutch	PDF
Consolidated accounts	31/12/2016	02/05/2017	04/07/2017	Dutch	PDF
Full model	31/12/2015	03/05/2016	01/06/2016	Dutch	PDF
Consolidated accounts	31/12/2015	03/05/2016	01/06/2016	Dutch	PDF
Full model	31/12/2014	05/05/2015	28/05/2015	Dutch	PDF
Consolidated accounts	31/12/2014	05/05/2015	03/06/2015	Dutch	PDF
Full model	31/12/2013	06/05/2014	04/06/2014	Dutch	PDF
Consolidated accounts	31/12/2013	06/05/2014	04/06/2014	Dutch	PDF

View all 31 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 74 ended

Active mandates

Nelly Souleymane

Director · since 14 février 2025 · until 04 mai 2027

Active

Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 04 mai 2027

Active

James Hartmann

Director · since 28 décembre 2023 · until 04 mai 2027

Active

MARS SARL

Director · since 28 décembre 2023 · until 04 mai 2027

Represented by Pascal Ghoson

Active

Anat Loewenstein

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Nathalie Laarakker

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Ended mandates

Nelly Souleymane

Director · since 14 février 2025 · until 06 mai 2025

Ended

Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 07 mai 2024

Ended

James Hartmann

Director · since 28 décembre 2023 · until 07 mai 2024

Ended

MARS SARL

Director · since 28 décembre 2023 · until 07 mai 2024

Represented by Pascal Ghoson

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Capital / shares27/08/2026
KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE,
PDF
Capital / shares30/06/2026
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Other15/05/2026
DIVERSEN
PDF
Capital / shares30/03/2026
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Capital / shares17/02/2026
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Other26/01/2026
DIVERSEN
PDF
Capital / shares04/11/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Other30/09/2025
DIVERSEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

27/05/2026
augmentation_capital
16/03/2026
augmentation_capital
14/01/2026
augmentation_capital
2025
Annual accounts 2025-3,2 M €↓
15/10/2025
augmentation_capital
03/10/2025
augmentation_capital
30/07/2025
augmentation_capital
25/07/2025
augmentation_capital
24/07/2025
augmentation_capital
23/07/2025
augmentation_capital
03/07/2025
augmentation_capital
03/06/2025
augmentation_capital
09/05/2025
augmentation_capital
21/03/2025
augmentation_capital
14/02/2025
nominationNelly Souleymane — onafhankelijke niet-uitvoerende bestuurder
10/01/2025
augmentation_capital
2024
Annual accounts 2024-199,2 k €↑
30/12/2024
augmentation_capital
04/12/2024
augmentation_capital
08/10/2024
augmentation_capital
23/09/2024
augmentation_capital
03/09/2024
autre
18/07/2024
augmentation_capital
22/05/2024
augmentation_capital
02/05/2024
augmentation_capital
10/04/2024
autre
25/03/2024
augmentation_capital
20/03/2024
augmentation_capital
29/02/2024
augmentation_capital
14/02/2024
augmentation_capital
2023
Annual accounts 2023-13,4 M €↑
28/12/2023
nominationCharles Paris de Bollardière — onafhankelijke niet-uitvoerende bestuurder
28/12/2023
nominationJames Hartmann — onafhankelijke niet-uitvoerende bestuurder
28/12/2023
nominationMARS SARL — Gedelegeerd Bestuurder
28/12/2023
nominationAndy Deene — CDO
28/12/2023
nominationPhilippe Barbeaux — CSO
06/07/2023
augmentation_capital
27/06/2023
augmentation_capital
12/05/2023
augmentation_capital
09/05/2023
augmentation_capital
05/05/2023
augmentation_capital
02/05/2023
augmentation_capital
25/04/2023
augmentation_capital
05/04/2023
augmentation_capital
28/03/2023
augmentation_capital
22/03/2023
augmentation_capital
2022
Annual accounts 2022-24,5 M €↑
12/10/2022
augmentation_capital
12/10/2022
augmentation_capital
13/09/2022
augmentation_capital
05/09/2022
augmentation_capital
17/08/2022
augmentation_capital
06/07/2022
augmentation_capital
07/06/2022
augmentation_capital
18/05/2022
augmentation_capital
03/05/2022
nominationPwC Bedrijfsrevisoren BV — commissaris
03/05/2022
reconductionThomas Clay — onafhankelijk niet-uitvoerend bestuurder
03/05/2022
reconductionMeRoNo BV — niet-uitvoerend bestuurder
03/05/2022
reconductionDr. David Guyer — onafhankelijk niet-uitvoerend bestuurder
03/05/2022
reconductionAdrienne Graves — onafhankelijk niet-uitvoerend bestuurder
03/05/2022
reconductionThomas Graney — uitvoerend bestuurder
15/04/2022
augmentation_capital
2021
Annual accounts 2021-36,7 M €↓
2020
Annual accounts 2020-26,9 M €↑
2019
Annual accounts 2019-50,2 M €↓
2018
Annual accounts 2018-36,9 M €↓
2018
Name changeOxurion NV
2017
Annual accounts 201723,8 M €↑
2016
Annual accounts 2016-67,3 M €↓
2015
Annual accounts 2015-29,4 M €↑
2014
Annual accounts 2014-51,2 M €↓
2013
Annual accounts 201314 M €↓
2012
Annual accounts 201220,8 M €↑
2011
Annual accounts 2011-31,5 M €↓
2010
Annual accounts 2010-26,8 M €↓
2008
Annual accounts 200814,1 M €
2008
Name changeThromboGenics
30/05/2006
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Oxurion

Overview

What does Oxurion do?

Trend over 17 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline